Abstract
Cepharanthine is diclofenac quinoline alkaloid isolated from rhizome of Stephania japonica. It could stimulate the reticuloendothelial system, then activate hematopoietic tissue, and promote myeloproliferation. The major clinical application of cepharanthine is to improve their immunity impaired by chemotherapy or radiotherapy in tumor patients. In addition, cepharanthine can increase the sensitivity of antitumor drugs. Now, it is commonly used as an adjuvant drug for anticancer treatment. In addition, it is also used as anti-pneumoconiosis drugs in China.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hasegawa S, Takahashi K. The effect of cepharanthine on pertussis. Jpn J Exp Med. 1949;20(2):229–34.
Huang, et al. The role of cepharanthine in the prevention and treatment of leukopenia. Foreign Med: Pharm. 1974;04:203–4.
Effects of five kinds of dibenzylisoquinoline alkaloids on experimental silicosis in rats. Health Res. 1977;02:92–8.
Cui, et al. An overview of pharmacological effects of caffeine. Chin Herb Med. 1995;09:502.
Ono M. Effect of cepharanthine on antitumor activity of 1-(2-tetrahydrofuryl)- 5-fluorouracil (FT-207)--5-fluorouracil delivery into tumor tissue. Nihon Gan Chiryo Gakkai Shi. 1989;24(7):1379–92.
Wu. Treatment of silicosis and coal workers’ pneumoconiosis by thalidomide. Ind Hyg Occup Dis. 1997;23(5):297–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China
About this chapter
Cite this chapter
Chu, SF., Kong, LL., Chen, NH. (2018). Cepharanthine. In: Natural Small Molecule Drugs from Plants. Springer, Singapore. https://doi.org/10.1007/978-981-10-8022-7_82
Download citation
DOI: https://doi.org/10.1007/978-981-10-8022-7_82
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8021-0
Online ISBN: 978-981-10-8022-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)